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Although the ACC
is not going to
come up with solu-
tions to the health
care cost problem
all on its own, we
can—and must—
contribute to the
policy debate with
our accumulated
experience, our best
medical judgment,
rigorous evidence,
and a commitment
to the integrity of
our profession and
of patient care.Several years ago Donald Berwick, MD, and colleagues at the Institute for Health-care Improvement articulated a vision for 21st-century health care. Their so-called“triple aim” focused on improving the experience of care, improving the health of
opulations, and reducing per capita costs of health care (1).
I think we all go into medicine with goals similar to the first 2 aims, but as physicians
e give little thought to the third. We do not teach medical students about our larger
ealth care systems or health policy, and training demands squeeze out the time to ex-
lore these issues unless an individual is particularly motivated. But because I believe we
ave an ethical responsibility to both our patients and our profession, and because cost is
o intertwined with health and the experience of care, I am going to depart from usual
ractice in this President’s Page and provide some background on the cost of health
are. I hope this context will help engender better appreciation for some of the ways the
merican College of Cardiology (ACC) is seeking to address certain aspects of the cur-
ent crisis and contribute reasonable solutions.
edicine versus health care. The U.S. medical system has many strengths. Not only
re training programs excellent, but academic medical centers are among the best in the
orld, and the system is prompt in providing care, even when it is highly specialized.
e are also continually improving technology, diagnosis, and treatment. Cardiology
lone has made exemplary progress in this regard, reducing morbidity and mortality
rom cardiovascular disease by more than 60% since 1950 (2).
The best medical-scientific expertise does not necessarily correlate with the best health
are, however. It has become common knowledge that America is behind many other devel-
ped countries in a number of areas, including infant mortality rates and longevity, and that
mericans often have less access to health resources (3–6). Yet health care in the United
tates costs more than it does in any other industrialized nation. In fact, while health care
osts have risen around the world over the past 4 decades, the United States has been out-
pending other developed countries the whole time, and health care expenditure as a percent
f the gross domestic product (GDP) has been consistently higher (3–7).
actors in rising costs. Could it be that America is simply a wealthier country and so
e simply choose to spend more on health care? Recent studies using 2008 data from
he Organisation for Economic Co-operation and Development (OECD) indicate that
here is, in fact, a strong relationship between a country’s wealth and the amount it
pends on health care (3–7). This makes sense, in that GDP per capita is a rough esti-
ate of ability to pay, but it accounts for only some of the difference in health care ex-
enditure. Even after adjusting for differences in GDP per capita, the United States still
pent about 40% more than would be predicted (7).
If our health outcomes are not better, and we do not get better quality from our health
ystem than other nations, then why are we spending so much? According to Princeton
conomist Uwe Reinhardt, there are 4 main factors contributing to “excess spending” in the
nited States (7):
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services;
2. we have greater administrative overhead;
3. we favor higher-cost, higher-tech procedures; and
4. we tend to practice defensive medicine.
The first 2 factors are structural, intrinsic to the ad hoc
system of payers and price-setting that has evolved in the
United States. A recent survey has shown that, of 23 dif-
ferent medical services and products ranging from atorva-
statin to coronary bypass, 22 were significantly cheaper in
other developed countries than in the United States (8,9).
An angiogram costs about $35 in Canada, $123 in Spain,
$320 in India, and $800 in the United States, while coro-
nary artery bypass costs an average of $10,000 to $20,000
in various European countries, but $68,000 in the United
States.
The domestic side of the story is equally astonishing.
Prices within the United States vary by as much as 10-
fold even among different hospitals in the same geo-
graphic region. This extraordinary range is due to perva-
sive price discrimination that reflects different degrees of
market power among private insurers (10). This in turn
contributes to the second major factor in the high cost of
our health care—higher administrative costs than other
countries with simpler health insurance systems. Just fig-
uring out what to bill to whom, let alone negotiating
these different prices, and trying to negotiate the care
maze takes a tremendous amount of resources. Data from
a McKinsey Global Institute study (11) suggests that the
amount of excess spending just on administration for pri-
vate insurers alone would have amounted to $150 billion
in 2008, more than enough to finance universal health
insurance that year.
It can be argued that large administrative overhead is
not actually a bad thing because it provides employment
for non-medical professionals or those not directly in-
volved in care. This is true, of course, but the problem is
that someone has to pay for these employees—either pri-
vate insurance, individual patients, or the government—
which brings us right back to the fundamentals of the
health care debate. Even more important, such thinking
fails to account for the incalculable cost of time, energy,
resources, and frustration to patients and the care team
who must navigate through a byzantine system to get pre-
certification, reimbursement, appeal denials of care, and
so forth.
Last but not least, cost pressures and the attempt to
shoehorn medicine into an unsuitable factory model of
production have placed great strain on the doctor–patient
relationship, an essential component of good care. Most
conspicuously, lack of time and less reliance on clinicaljudgment combined with (consciously or subconsciously)
defensive medicine have led to a greater reliance on test-
ing and state-of-the-art technology. While some of the
newer diagnostic and therapeutic advances have certainly
improved objectivity, accuracy, and outcome, some have
had a similar effect but at a significantly higher cost—and
some would not be performed nearly as frequently if our
system rewarded physicians for spending time with pa-
tients, taking a careful history, and building the trust that
helps patients make better medical decisions and discour-
ages frivolous lawsuits. Duplicative testing and fragmented
care are further byproducts of such a system.
What can we do? All these factors add to the cost of
health care, but they also point to potential solutions.
The ACC is working on the following fronts to help
cardiology achieve the triple aim:
1. Make the most of quality data and registries: The
ollege has led the way in developing evidence-based
uidelines, performance measures, and appropriate use
riteria (AUC), and in putting these tools directly into
he hands of cardiovascular professionals at the point of
are. For example, the registries under the National Car-
iovascular Data Registry (NCDR®) umbrella are useful
ools for identifying gaps in care and improving practice
tandards. The use of NCDR data has already identified
riteria to help guide the application of percutaneous cor-
nary interventions (PCIs), implantable cardioverter-
efibrillators (ICDs), coronary angiography, and cardiac
atheterization. Pilot data on stress nuclear imaging, ac-
uired in collaboration with United Health Care, prompted
the Imaging in FOCUS initiative, which decreased inappro-
priate testing from 11% to 7% in its initial phase. The Col-
lege is also using NCDR data to track and monitor cardio-
vascular-related hospital readmissions to help the ACC’s
Hospital to Home Initiative (H2H) shape more effective
strategies for smooth recovery. Similarly, NCDR data played
a major role in identifying variations in door-to-balloon
(D2B) times. This resulted in the highly successful D2B
Alliance and nationwide improvement in meeting the rec-
ommended D2B time of 90 min or less (12).
2. Test different models of payment reform: The Col-
lege firmly believes that to reduce U.S. health care spend-
ing and maintain good quality care will require the align-
ment of payment incentives with improved, data-driven
outcomes. Heath care professionals, payers, hospitals, and
industry need to work collaboratively and align incentives
for improved health and outcomes to achieve more sus-
tainable health care systems that ultimately cover all indi-
viduals. Patients need to be engaged and accountable
partners in this endeavor. Partnerships around health in-
formation technology are also critical in order to effec-
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nate duplicative and unnecessary testing and procedures,
and better enable patient involvement and understanding
of their disease and treatment options. The ACC is de-
veloping several progressive payment models for cardio-
vascular care which address documented clinical quality,
resource use, and cost variation and which could be
broadened to the larger health care arena if successful.
For example, the ACC’s SMARTCare projects in Wis-
consin and Florida would bundle payments for a variety
of providers involved in the treatment of stable ischemic
heart disease. Bundling could cover an entire episode of
care or be broken into smaller bundles that reflect patient
preferences for care. This model could help eliminate unnec-
essary procedures, reduce administrative burdens related to
pre-authorization of individual services, and prompt health
care teams to better coordinate patient care. It could also
facilitate adherence to guidelines and AUC and encourage
registry participation. The proof is in the data, however, and
we will be tracking the response to bundling for the next few
years before drawing robust conclusions.
Another option is population health management, or
“comprehensive care” payment models for patients who
receive primary care from specialists such as cardiologists.
While recent Accountable Care Organization (ACO) reg-
ulations have focused on primary care patients, some pa-
tients with a significant illness, such as congestive heart
failure, receive comprehensive care from a cardiologist.
We can test the feasibility of the medical home model
and the ACO model for this type of medically complex
patient for application in specialty practices.
3. Make the right information more accessible to both
patients and providers. Given the practice constraints
most physicians labor under, taking the time to engage
patients in their own care and help them make lifestyle
changes can be challenging. The ACC’s investment in
CardioSmart signals the importance we attach to patient
education, and our revision of the website this year should
make engaging patients that much easier.
The ACC is equally committed to meeting the educa-
tional and professional needs of the entire cardiac care team.
We want to make it as convenient as possible for cardiac
care providers to stay up-to-date on the latest science and
education and to be prepared to work together to treat a
growing number of patients with cardiovascular disease. Our
new generation of physicians and allied of the principles of
cost-effective, quality care, and outcomes. This comprehen-
sive approach to health care needs to be included and em-
phasized in the curriculum of various training programs.
There are no straightforward answers to the problems
that beset our system; any solution is going to be tempo-rarily painful to some constituency. One advantage of our
byzantine and balkanized system, however, is that it af-
fords us an opportunity to experiment. Although the
ACC is not going to come up with solutions to the
health care cost problem all on its own, we can—and
must—contribute to the policy debate with our accumu-
lated experience, our best medical judgment, rigorous evi-
dence, and a commitment to the integrity of our profes-
sion and of patient care.
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